<?xml version="1.0" encoding="utf-8"?>		<!-- generator="InstaScript v2.0" -->
		<rss version="2.0" 
		xmlns:content="http://purl.org/rss/1.0/modules/content/"
		xmlns:wfw="http://wellformedweb.org/CommentAPI/"
		xmlns:dc="http://purl.org/dc/elements/1.1/"
		xmlns:trackback="http://madskills.com/public/xml/rss/module/trackback/"
		xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule"
		xmlns:media="http://search.yahoo.com/mrss/"
		xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
		xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#"
		xmlns:amp="http://www.adobe.com/amp/1.0"
		xmlns:dcterms="http://purl.org/dc/terms/"
		xmlns:gm="http://www.google.com/schemas/gm/1.1">

		<channel>
		<title>Genentech - Latest Popular Stories, Instablogs Community </title>
		<link>http://www.instablogs.com/genentech/</link>
		<description>Genentech - Latest Popular Stories powered by Instablogs Community.</description>
		<image>
			<url>http://www.instablogs.com/site-img/insta-slogo.gif</url>
			<title>Instablogs Community</title>
			<link>http://www.instablogs.com/genentech/</link>
		</image>
		<language>en-us</language>
		<generator>Instascript 2.0 http://www.instablogs.com</generator>
		<lastBuildDate>
		Thu, 16 Oct 2008 20:16:59 +0000		</lastBuildDate>
					<item>
				<title>Genentech's Raptiva receives new FDA warning</title>
									<link>http://www.instablogs.com/entry/genentechs-raptiva-receives-new-fda-warning/</link>
					<guid isPermaLink="true">http://www.instablogs.com/entry/genentechs-raptiva-receives-new-fda-warning/</guid>
				
				<dc:creator>AP</dc:creator>
								<description><![CDATA[<img src="" align="right" /><p>	The Food and Drug Administration said Thursday it will update the labeling of Genentech Inc.&#8217;s psoriasis drug Raptiva to highlight the risk of several bacterial and viral...</p>]]></description>

				<content:encoded><![CDATA[	<p>The Food and Drug Administration said Thursday it will update the labeling of Genentech Inc.&#8217;s psoriasis drug Raptiva to highlight the risk of several bacterial and viral conditions.
</p>
]]></content:encoded>
				<pubDate>Thu, 16 Oct 2008 20:16:59 +0000</pubDate>
				<category>Genentech</category><category>FDA</category><category>Warning</category><category>Business</category>								
			</item>
						<item>
				<title>Correction: Genentech earnings story</title>
									<link>http://www.instablogs.com/entry/correction-genentech-earnings-story/</link>
					<guid isPermaLink="true">http://www.instablogs.com/entry/correction-genentech-earnings-story/</guid>
				
				<dc:creator>AP</dc:creator>
								<description><![CDATA[<img src="" align="right" /><p>	In an Oct. 14 story about Genentech&#8217;s third-quarter results, The Associated Press erroneously reported financial forecasts by analysts surveyed by Thomson Reuters, wrongly indicating that Genentech had met...</p>]]></description>

				<content:encoded><![CDATA[	<p>In an Oct. 14 story about Genentech&#8217;s third-quarter results, The Associated Press erroneously reported financial forecasts by analysts surveyed by Thomson Reuters, wrongly indicating that Genentech had met expectations.
</p>
]]></content:encoded>
				<pubDate>Thu, 16 Oct 2008 19:25:45 +0000</pubDate>
				<category>Earns</category><category>Genentech</category><category>CORRECTIVE</category><category>Business</category>								
			</item>
						<item>
				<title>Genentech 3Q profit rises, meets forecast</title>
									<link>http://www.instablogs.com/entry/genentech-3q-profit-rises-meets-forecast/</link>
					<guid isPermaLink="true">http://www.instablogs.com/entry/genentech-3q-profit-rises-meets-forecast/</guid>
				
				<dc:creator>AP</dc:creator>
								<description><![CDATA[<img src="" align="right" /><p>	Genentech says its third-quarter profit rose 6.7 percent on rising sales of key cancer drugs, in line with Wall Street forecasts.

</p>]]></description>

				<content:encoded><![CDATA[	<p>Genentech says its third-quarter profit rose 6.7 percent on rising sales of key cancer drugs, in line with Wall Street forecasts.
</p>
]]></content:encoded>
				<pubDate>Tue, 14 Oct 2008 20:23:14 +0000</pubDate>
				<category>Earns</category><category>Genentech</category><category>Business</category><category>Wall Street</category>								
			</item>
						<item>
				<title>FDA cites brain virus with Genentech, Biogen drug</title>
									<link>http://www.instablogs.com/entry/fda-cites-brain-virus-with-genentech-biogen-drug/</link>
					<guid isPermaLink="true">http://www.instablogs.com/entry/fda-cites-brain-virus-with-genentech-biogen-drug/</guid>
				
				<dc:creator>AP</dc:creator>
								<description><![CDATA[<img src="" align="right" /><p>	Federal regualtors said Thursday one case of a deadly brain infection has been reported in a patient taking Genentech and Biogen Idec&#8217;s blockbuster arthritis and cancer drug...</p>]]></description>

				<content:encoded><![CDATA[	<p>Federal regualtors said Thursday one case of a deadly brain infection has been reported in a patient taking Genentech and Biogen Idec&#8217;s blockbuster arthritis and cancer drug Rituxan.
</p>
]]></content:encoded>
				<pubDate>Thu, 11 Sep 2008 18:40:02 +0000</pubDate>
				<category>Genentech</category><category>FDA</category><category>Warning</category><category>Business</category>								
			</item>
						<item>
				<title>Genentech rejects Roche's $43.7 billion bid</title>
									<link>http://www.instablogs.com/entry/genentech-rejects-roches-437-billion-bid/</link>
					<guid isPermaLink="true">http://www.instablogs.com/entry/genentech-rejects-roches-437-billion-bid/</guid>
				
				<dc:creator>AP</dc:creator>
								<description><![CDATA[<img src="" align="right" /><p>	Biotechnology giant Genentech is turning down a buyout offer from its majority owner Roche, saying the $43.7 billion takeover bid undervalues the company.

</p>]]></description>

				<content:encoded><![CDATA[	<p>Biotechnology giant Genentech is turning down a buyout offer from its majority owner Roche, saying the $43.7 billion takeover bid undervalues the company.
</p>
]]></content:encoded>
				<pubDate>Wed, 13 Aug 2008 14:00:45 +0000</pubDate>
				<category>Genentech</category><category>Roche</category><category>Buyout</category><category>Offer</category>								
			</item>
						<item>
				<title>Genentech mulls Roche offer as stock surges</title>
									<link>http://www.instablogs.com/entry/genentech-mulls-roche-offer-as-stock-surges/</link>
					<guid isPermaLink="true">http://www.instablogs.com/entry/genentech-mulls-roche-offer-as-stock-surges/</guid>
				
				<dc:creator>AP</dc:creator>
								<description><![CDATA[<img src="" align="right" /><p>	Biotechnology pioneer Genentech Inc. mulled Roche Holding&#8217;s $43.7 billion offer for its remaining shares Monday as investors made clear their feelings that the Swiss pharmaceutical giant should pay considerably more.But some analysts said...</p>]]></description>

				<content:encoded><![CDATA[	<p>Biotechnology pioneer Genentech Inc. mulled Roche Holding&#8217;s $43.7 billion offer for its remaining shares Monday as investors made clear their feelings that the Swiss pharmaceutical giant should pay considerably more.But some analysts said Roche, already...
</p>
]]></content:encoded>
				<pubDate>Mon, 21 Jul 2008 20:45:41 +0000</pubDate>
				<category>Roche</category><category>Genentech</category><category>Business</category><category>Biotechnology</category>								
			</item>
						<item>
				<title>Roche offers $43.7B for rest of Genentech</title>
									<link>http://www.instablogs.com/entry/roche-offers-437b-for-rest-of-genentech/</link>
					<guid isPermaLink="true">http://www.instablogs.com/entry/roche-offers-437b-for-rest-of-genentech/</guid>
				
				<dc:creator>AP</dc:creator>
								<description><![CDATA[<img src="" align="right" /><p>	Swiss drugmaker Roche on Monday offered $43.7 billion for the remaining shares of its U.S. biotech partner Genentech Inc. in a move to boost its stature in the market for drugs to fight cancer and other diseases.Roche shares dropped 2 percent after...</p>]]></description>

				<content:encoded><![CDATA[	<p>Swiss drugmaker Roche on Monday offered $43.7 billion for the remaining shares of its U.S. biotech partner Genentech Inc. in a move to boost its stature in the market for drugs to fight cancer and other diseases.Roche shares dropped 2 percent after the...
</p>
]]></content:encoded>
				<pubDate>Mon, 21 Jul 2008 12:06:47 +0000</pubDate>
				<category>Switzerland</category><category>Roche</category><category>Genentech</category><category>Business</category>								
			</item>
						<item>
				<title>Stocks set to open higher amid MandA, earnings</title>
									<link>http://www.instablogs.com/entry/stocks-set-to-open-higher-amid-ma-earnings/</link>
					<guid isPermaLink="true">http://www.instablogs.com/entry/stocks-set-to-open-higher-amid-ma-earnings/</guid>
				
				<dc:creator>AP</dc:creator>
								<description><![CDATA[<img src="" align="right" /><p>	Wall Street looked to open slightly higher Monday after investors cheered a return to big merger and acquisition deals with Roche Holding&#8217;s bid to buy Genentech Inc.The Swiss drug maker offered to buy Genentech for $43.7 million, making it...</p>]]></description>

				<content:encoded><![CDATA[	<p>Wall Street looked to open slightly higher Monday after investors cheered a return to big merger and acquisition deals with Roche Holding&#8217;s bid to buy Genentech Inc.The Swiss drug maker offered to buy Genentech for $43.7 million, making it the...
</p>
]]></content:encoded>
				<pubDate>Mon, 21 Jul 2008 10:55:11 +0000</pubDate>
				<category>Wall</category><category>Street</category><category>Business</category><category>Wall Street</category>								
			</item>
						<item>
				<title>Roche offers $44B for remaining Genentech shares</title>
									<link>http://www.instablogs.com/entry/roche-offers-44b-for-remaining-genentech-shares/</link>
					<guid isPermaLink="true">http://www.instablogs.com/entry/roche-offers-44b-for-remaining-genentech-shares/</guid>
				
				<dc:creator>AP</dc:creator>
								<description><![CDATA[<img src="" align="right" /><p>	Roche Holding on Monday said it was offering $43.7 billion to take over the remaining shares of Genentech Inc.Roche, which already owns 55.9 percent of the San Francisco-based drug maker, said it was offering $89 per share, 8.8 percent above the...</p>]]></description>

				<content:encoded><![CDATA[	<p>Roche Holding on Monday said it was offering $43.7 billion to take over the remaining shares of Genentech Inc.Roche, which already owns 55.9 percent of the San Francisco-based drug maker, said it was offering $89 per share, 8.8 percent above the closing...
</p>
]]></content:encoded>
				<pubDate>Mon, 21 Jul 2008 06:01:34 +0000</pubDate>
				<category>Switzerland</category><category>Roche</category><category>Genentech</category><category>Business</category>								
			</item>
						<item>
				<title>Court cuts $200M from royalty judgment against Genentech</title>
									<link>http://www.instablogs.com/entry/court-cuts-200m-from-royalty-judgment-against-genentech/</link>
					<guid isPermaLink="true">http://www.instablogs.com/entry/court-cuts-200m-from-royalty-judgment-against-genentech/</guid>
				
				<dc:creator>AP</dc:creator>
								<description><![CDATA[<img src="" align="right" /><p>	The California Supreme Court has slashed $200 million from a judgment against Genentech Inc.The South San Francisco-based biotechnology company was ordered to pay $500 million to a Southern California hospital for failing to pay royalties after...</p>]]></description>

				<content:encoded><![CDATA[	<p>The California Supreme Court has slashed $200 million from a judgment against Genentech Inc.The South San Francisco-based biotechnology company was ordered to pay $500 million to a Southern California hospital for failing to pay royalties after City of...
</p>
]]></content:encoded>
				<pubDate>Thu, 24 Apr 2008 18:51:03 +0000</pubDate>
				<category>Biotech</category><category>Lawsuit</category><category>Technology</category><category>Business</category>								
			</item>
					</channel>
		</rss>
			